IAC Inc tiene un precio objetivo de consenso de $57.26 basado en las calificaciones de 19 analistas. El máximo es $112, emitido por Credit Suisse el agosto 10, 2023. El mínimo es $14, emitido por Macquarie el noviembre 14, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Barclays y Truist Securities el noviembre 5, 2025, respectivamente. Con un precio objetivo promedio de $46.33 entre UBS, Barclays y Truist Securities, hay una 39.47% upside implícita para IAC Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/05/2025 | 17.4% | UBS | $41 → $39 | Maintains | Neutral | |||
11/05/2025 | 44.49% | Barclays | $52 → $48 | Maintains | Overweight | |||
11/05/2025 | 56.53% | Truist Securities | $57 → $52 | Maintains | Buy | |||
11/05/2025 | 71.58% | Benchmark | $60 → $57 | Maintains | Buy | |||
11/03/2025 | 23.42% | Keybanc | $45 → $41 | Maintains | Overweight | |||
08/06/2025 | 17.4% | Piper Sandler | $44 → $39 | Maintains | Neutral | |||
08/06/2025 | 23.42% | UBS | $38 → $41 | Maintains | Neutral | |||
08/06/2025 | 80.61% | Benchmark | $63 → $60 | Maintains | Buy | |||
08/06/2025 | 35.46% | Keybanc | $49 → $45 | Maintains | Overweight | |||
08/06/2025 | 71.58% | Truist Securities | $61 → $57 | Maintains | Buy | |||
08/06/2025 | 65.56% | Oppenheimer | $60 → $55 | Maintains | Outperform | |||
06/10/2025 | 41.48% | JMP Securities | $64 → $47 | Maintains | Market Outperform | |||
05/07/2025 | 38.47% | Goldman Sachs | $60 → $46 | Maintains | Buy | |||
05/07/2025 | 14.39% | UBS | $54 → $38 | Maintains | Neutral | |||
05/07/2025 | 32.45% | Piper Sandler | $54 → $44 | Maintains | Neutral | |||
05/06/2025 | 56.53% | Barclays | $61 → $52 | Maintains | Overweight | |||
05/05/2025 | 47.5% | Keybanc | $64 → $49 | Maintains | Overweight | |||
04/25/2025 | 35.46% | Citigroup | $47.55 → $45 | Maintains | Buy | |||
04/22/2025 | 35.46% | JP Morgan | $60 → $45 | Maintains | Overweight | |||
03/21/2025 | 80.61% | JP Morgan | → $60 | Reinstates | → Overweight | |||
02/18/2025 | 92.66% | Keybanc | $60 → $64 | Maintains | Overweight | |||
02/13/2025 | 110.72% | Oppenheimer | $72 → $70 | Maintains | Outperform | |||
02/13/2025 | 201.02% | Benchmark | $105 → $100 | Maintains | Buy | |||
02/13/2025 | 92.66% | JMP Securities | $70 → $64 | Maintains | Market Outperform | |||
02/13/2025 | 62.55% | UBS | $55 → $54 | Maintains | Neutral | |||
02/13/2025 | 128.78% | Truist Securities | $80 → $76 | Maintains | Buy | |||
02/13/2025 | 83.62% | Barclays | $66 → $61 | Maintains | Overweight | |||
01/31/2025 | 74.59% | Citigroup | $56 → $58 | Maintains | Buy | |||
01/03/2025 | 68.57% | Citigroup | $60 → $56 | Maintains | Buy | |||
12/16/2024 | 110.72% | JMP Securities | $70 → $70 | Reiterates | Market Outperform → Market Outperform | |||
12/10/2024 | 62.55% | Piper Sandler | $68 → $54 | Downgrade | Overweight → Neutral | |||
11/20/2024 | 80.61% | Keybanc | $66 → $60 | Maintains | Overweight | |||
11/14/2024 | -57.86% | Macquarie | $14 → $14 | Maintains | Outperform | |||
11/13/2024 | 65.56% | UBS | $57 → $55 | Maintains | Neutral | |||
11/13/2024 | 131.79% | TD Cowen | $82 → $77 | Maintains | Buy | |||
11/13/2024 | 216.07% | Benchmark | $110 → $105 | Maintains | Buy | |||
11/13/2024 | 140.82% | Truist Securities | $88 → $80 | Maintains | Buy | |||
11/13/2024 | 98.68% | Barclays | $70 → $66 | Maintains | Overweight | |||
11/12/2024 | 231.13% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
10/28/2024 | 71.58% | UBS | $64 → $57 | Maintains | Neutral | |||
08/27/2024 | 231.13% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
08/16/2024 | 98.68% | Keybanc | $67 → $66 | Maintains | Overweight | |||
08/08/2024 | 98.68% | Citigroup | $70 → $66 | Maintains | Buy | |||
08/08/2024 | 110.72% | Barclays | $73 → $70 | Maintains | Overweight | |||
08/08/2024 | 231.13% | Benchmark | $110 → $110 | Reiterates | Buy → Buy | |||
08/08/2024 | 164.9% | Truist Securities | $87 → $88 | Maintains | Buy | |||
07/09/2024 | 134.8% | JMP Securities | → $78 | Initiates | → Market Outperform | |||
05/14/2024 | 152.86% | Wells Fargo | $82 → $84 | Maintains | Overweight | |||
05/13/2024 | 101.69% | Keybanc | $64 → $67 | Maintains | Overweight | |||
05/10/2024 | 161.89% | Truist Securities | $80 → $87 | Maintains | Buy | |||
05/09/2024 | 110.72% | Citigroup | $72 → $70 | Maintains | Buy | |||
05/09/2024 | 125.77% | Oppenheimer | $65 → $75 | Maintains | Outperform | |||
05/09/2024 | 119.75% | Barclays | $72 → $73 | Maintains | Overweight | |||
05/03/2024 | 92.66% | Keybanc | $72 → $64 | Maintains | Overweight | |||
02/16/2024 | 116.74% | Keybanc | $70 → $72 | Maintains | Overweight | |||
02/15/2024 | 92.66% | UBS | $60 → $64 | Maintains | Neutral | |||
02/15/2024 | 116.74% | Barclays | $62 → $72 | Maintains | Overweight | |||
02/15/2024 | 140.82% | Truist Securities | $77 → $80 | Maintains | Buy | |||
02/13/2024 | 110.72% | Keybanc | $68 → $70 | Maintains | Overweight | |||
11/27/2023 | 104.7% | Keybanc | $72 → $68 | Maintains | Overweight | |||
11/17/2023 | 62.55% | UBS | $66 → $54 | Maintains | Neutral | |||
11/09/2023 | 140.82% | Truist Securities | $84 → $80 | Maintains | Buy | |||
11/09/2023 | 89.64% | Piper Sandler | $74 → $63 | Maintains | Overweight | |||
11/09/2023 | 231.13% | Benchmark | $115 → $110 | Maintains | Buy | |||
11/07/2023 | 116.74% | Keybanc | $81 → $72 | Maintains | Overweight | |||
09/13/2023 | 152.86% | Truist Securities | → $84 | Reiterates | Buy → Buy | |||
08/28/2023 | 98.68% | UBS | $72 → $66 | Maintains | Neutral | |||
08/23/2023 | 143.83% | Keybanc | $82 → $81 | Maintains | Overweight | |||
08/21/2023 | 152.86% | Truist Securities | → $84 | Reiterates | Buy → Buy | |||
08/10/2023 | 140.82% | JP Morgan | $85 → $80 | Maintains | Overweight | |||
08/10/2023 | 110.72% | Oppenheimer | $75 → $70 | Maintains | Outperform | |||
08/10/2023 | 246.18% | Benchmark | $120 → $115 | Maintains | Buy | |||
08/10/2023 | 237.15% | Credit Suisse | $123 → $112 | Maintains | Outperform | |||
08/10/2023 | 107.71% | Citigroup | $71 → $69 | Maintains | Buy | |||
08/10/2023 | 125.77% | Barclays | $85 → $75 | Maintains | Overweight | |||
08/07/2023 | 146.84% | Keybanc | $72 → $82 | Maintains | Overweight | |||
05/30/2023 | 116.74% | Keybanc | $65 → $72 | Maintains | Overweight | |||
05/18/2023 | 140.82% | Jefferies | $70 → $80 | Maintains | Buy | |||
05/12/2023 | 113.73% | Citigroup | $64 → $71 | Maintains | Buy | |||
05/12/2023 | 137.81% | Wells Fargo | $70 → $79 | Maintains | Overweight | |||
05/11/2023 | 270.26% | Credit Suisse | $120 → $123 | Maintains | Outperform | |||
05/11/2023 | 164.9% | Truist Securities | $85 → $88 | Maintains | Buy | |||
05/11/2023 | 83.62% | UBS | $54 → $61 | Maintains | Neutral | |||
05/11/2023 | 125.77% | Oppenheimer | $70 → $75 | Maintains | Outperform | |||
05/11/2023 | 155.87% | Barclays | $75 → $85 | Maintains | Overweight | |||
05/03/2023 | 92.66% | Citigroup | $67 → $64 | Maintains | Buy | |||
02/15/2023 | 110.72% | Jefferies | $65 → $70 | Maintains | Buy | |||
02/15/2023 | 122.76% | Piper Sandler | $67 → $74 | Maintains | Overweight | |||
02/15/2023 | 62.55% | UBS | $46 → $54 | Upgrade | Sell → Neutral | |||
02/15/2023 | 122.76% | Goldman Sachs | $83 → $74 | Maintains | Buy | |||
02/15/2023 | 110.72% | Oppenheimer | → $70 | Reiterates | → Outperform | |||
02/15/2023 | 261.23% | Benchmark | $130 → $120 | Maintains | Buy | |||
02/15/2023 | 125.77% | Barclays | $70 → $75 | Maintains | Overweight | |||
02/15/2023 | 261.23% | Credit Suisse | $108 → $120 | Maintains | Outperform | |||
02/13/2023 | 101.69% | Citigroup | $60 → $67 | Maintains | Buy | |||
02/10/2023 | 291.33% | Benchmark | → $130 | Reiterates | → Buy | |||
01/19/2023 | 110.72% | Wells Fargo | $85 → $70 | Maintains | Overweight | |||
12/13/2022 | 80.61% | Citigroup | → $60 | Initiates | → Buy | |||
12/02/2022 | 38.47% | UBS | → $46 | Initiates | → Sell |
El último precio objetivo de IAC (NASDAQ:IAC) fue comunicado por UBS el noviembre 5, 2025. La firma de analistas fijó un precio objetivo para $39.00 que espera IAC a rise dentro de 12 meses (un posible 17.40% upside). 32 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para IAC (NASDAQ:IAC) fue proporcionada por UBS, y IAC mantuvo su neutral calificación.
La última revisión al alza de IAC Inc se produjo en febrero 15, 2023, cuando UBS elevó su precio objetivo a $54. UBS anteriormente tenía a sell para IAC Inc.
La última revisión a la baja de IAC Inc se produjo en diciembre 10, 2024, cuando Piper Sandler cambió su precio objetivo de $68 a $54 para IAC Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de IAC, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de IAC se registró el noviembre 5, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 5, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de IAC (IAC) fue un mantuvo con un precio objetivo de $41.00 a $39.00. El precio actual al que cotiza IAC (IAC) es de $33.22, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.